Key data

aantal-medewerkers-en.png
formele-opleidingen-en.png
aantal-nieuwe-medewerkers-en.png
ziekteverzuim-ongevallen-en.png

In short

GRI.jpeg

The Janssen Campus employed 4,517 people in 2013, of whom 55.7 % men and 44.3 % women. That is 69 fewer than the previous year.

As regards occupational safety, J&J expects a further reduction in Lost Work Day Cases and Serious Injury/Illness Cases under the Healthy Future 2015 goals of each site. Those are US indicators related to our Belgian degrees of frequency and seriousness. In 2013, there were 21 accidents involving absence from work on the Janssen Campus, resulting in 639 lost workdays. What is remarkable is the low degree of frequency and seriousness, giving Janssen a better rating than the average in the pharmaceutical industry (9.82) and markedly better than in the chemical industry (10.7).


167289246.jpg

Detailed data 2013

Employees

JANSSEN Pharmaceutica NV + J.C. General Services CVBA

2010201120122013
Number of employees
Men2.2442.2712.3542.308
Women1.6111.6031.6631.675
Total3.8553.8744.0173.983
Ratio men/women general
Men58%59%59%58%
Women42%41%41%42%
Number of full-time employees
Men2.0882.0952.1702.105
Women9609361.0131.005
Total3.0483.0313.1833.110
Number of part-time employees
Men156176184203
Women651667650670
Total807843834873
Number of employees with an indefinite employment contract
Men2.1812.1322.1902.198
Women1.5691.5271.5851.604
Total3.7503.6593.7753.802
Number of employees with a fixed-term employment contract
Men63139164110
Women42767871
Total105215242181
Number of nationalities35394242
Number of scientists----

    JANSSEN Cilag NV

    2010201120122013
    Number of employees
    Men80787763
    Women101106110102
    Total181184187165
    Ratio men/women general
    Men44%42%41%38%
    Women56%58%59%62%
    Number of full-time employees
    Men74707057
    Women68697266
    Total142139142123
    Number of part-time employees
    Men6876
    Women33373836
    Total39454542
    Number of employees with an indefinite employment contract
    Men78787563
    Women99100105100
    Total177178180163
    Number of employees with a fixed-term employment contract
    Men2020
    Women2652
    Total4672
    Number of nationalities4455

      JANSSEN Infectious Diseases & Diagnostics BVBA

      2010201120122013
      Number of employees
      Men144153155147
      Women197224227222
      Total341377382369
      Ratio men/women general
      Men42%41%41%40%
      Women58%59%59%60%
      Number of full-time employees
      Men142149152143
      Women142162166151
      Total284311318294
      Number of part-time employees
      Men2434
      Women55626171
      Total57666475
      Number of employees with an indefinite employment contract
      Men143148152146
      Women192211214213
      Total335359366359
      Number of employees with a fixed-term employment contract
      Men1531
      Women513139
      Total6181610
      Number of nationalities15161716
      Number of scientists----

        Personnel evolution

        JANSSEN Pharmaceutica NV + J.C. General Services CVBA

        2010201120122013
        Number of new employees
        Men93200246112
        Women7411214398
        Total167312389210
        >2555959559
        26-356411917178
        36-4538719553
        45-5510262517
        56-640133
        Total167312389210
        Number of staff taking voluntary redundancy
        Men37492622
        Women24251818
        Total61744440
        >255752
        26-3526312417
        36-4523331317
        45-556324
        56-641000
        61744440
        Voluntary termination of employment (% of total staff)
        1.43%1.91%1.1%1,00%
        Formal employee representation
        jajajaja

          JANSSEN Cilag NV

          2010201120122013
          Number of new employees
          Men7652
          Women1111168
          Total18172110
          >250240
          26-3558104
          36-459353
          45-553423
          56-641000
          Total18172110
          Number of staff taking voluntary redundancy
          Men2211
          Women4101
          Total6312
          >250000
          26-351301
          36-455001
          45-550010
          56-640000
          Total6312
          Voluntary termination of employment (% of total staff)
          3.31%1.65%0.54%1,21%
          Formal employee representation
          jajajaja

            JANSSEN Infectious Diseases & Diagnostics BVBA

            2010201120122013
            Number of new employees
            Men42182
            Women1637186
            Total2058268
            >256241
            26-351241182
            36-451914
            45-551630
            56-640001
            Total2058268
            Number of staff taking voluntary redundancy
            Men6803
            Women5474
            Total111277
            >250020
            26-355223
            36-454834
            45-552200
            56-640000
            Total111277
            Voluntary termination of employment (% of total staff)
            3.24%3.21%1.85%1,90%
            Formal employee representation
            jajajaja

              Management committee

              JANSSEN Pharmaceutica NV + J.C. General Services CVBA

              Members of the management committee2010201120122013
              Men23222217
              Women2212
              Total25242319
              >250000
              26-350000
              36-455655
              45-5511976
              56-644464
              Unknown (US employee)5554
              Total25242319

                JANSSEN Cilag NV

                Members of the management committee2010201120122013
                Men5536
                Women1122
                Total6658
                >250000
                26-350012
                36-451111
                45-554433
                56-641100
                Unknown (US employee)2
                Total6658

                  JANSSEN Infectious Diseases & Diagnostics BVBA

                  Members of the management committee2010201120122013
                  Men7766
                  Women3332
                  Total101098
                  >250000
                  26-351110
                  36-454433
                  45-553444
                  56-641111
                  Unknown (US employee)1
                  Total101098

                    Training

                    JANSSEN Pharmaceutica NV + J.C. General Services CVBA

                    2010201120122013
                    Net cost for the company per employee (in euros)1.157 €1.462 €2.022 €2.054 €
                    Total number of training hours received110.198126.321142.861117.399
                    Average number of training course hours29333629
                    Average number of training initiatives per employee27314847
                    % working hours2,082,282,522,12

                      JANSSEN Cilag NV

                      2010201120122013
                      Net cost for the company per employee (in euros)496 €2.321 €2.388 €1.273 €
                      Total number of training hours received9462.810,005.838,003.691,00
                      Average number of training course hours5153122
                      Average number of training initiatives per employeeno data39
                      % working hoursno data1,36%

                        JANSSEN Infectious Diseases & Diagnostics BVBA

                        2010201120122013
                        Net cost for the company per employee (in euros)773 €1.083 €1.729 €2.066 €
                        Total number of training hours received5.330,008.117,00,5812.716,009.622,00
                        Average number of training course hours16223326
                        Average number of training initiatives per employeeno data available21,8929,8128,40
                        % working hoursno data available1.142,111,64

                          Sickness absenteeism

                          JANSSEN Pharmaceutica NV + J.C. General Services CVBA

                          2010201120122013
                          Sickness absenteeism (% of total working hours)4,384,714,684,92

                            JANSSEN Cilag NV

                            2010201120122013
                            Sickness absenteeism (% of total working hours)3,243,433,333,75

                              JANSSEN Infectious Diseases & Diagnostics BVBA

                              2010201120122013
                              Sickness absenteeism (% of total working hours)1,111,421,582,56

                                Accidents

                                JANSSEN Pharmaceutica NV

                                2010201120122013
                                Days of absence from work (due to work accidents)368271350639
                                Number of accidents with absence from work29141821
                                Frequency rate
                                (ratio of number of accidents with absence from work ( * 1000000) divided by the number of hours worked)
                                4,992,323,083,62
                                Degree of severity
                                (ratio of number of days of absence from work ( * 1000) divided by the number of hours worked)
                                0,060,040,060,11

                                  JANSSEN Cilag NV

                                  2010201120122013
                                  Days of absence from work (due to work accidents)no data available006
                                  Number of accidents with absence from workno data available001
                                  Frequency rate
                                  (ratio of number of accidents with absence from work ( * 1000000) divided by the number of hours worked)
                                  no data available004,21
                                  Degree of severity
                                  (ratio of number of days of absence from work ( * 1000) divided by the number of hours worked)
                                  no data available000,03

                                    JANSSEN Infectious Diseases & Diagnostics BVBA

                                    2010201120122013
                                    Days of absence from work (due to work accidents)7750
                                    Number of accidents with absence from work110
                                    Frequency rate
                                    (ratio of number of accidents with absence from work ( * 1000000) divided by the number of hours worked)
                                    1,881,740
                                    Degree of severity
                                    (ratio of number of days of absence from work ( * 1000) divided by the number of hours worked)
                                    0,010,1300

                                      J.C. General Services CVBA

                                      2010201120122013
                                      Days of absence from work (due to work accidents)000
                                      Number of accidents with absence from work000
                                      Frequency rate
                                      (ratio of number of accidents with absence from work ( * 1000000) divided by the number of hours worked)
                                      000
                                      Degree of severity
                                      (ratio of number of days of absence from work ( * 1000) divided by the number of hours worked)
                                      000

                                        Evolution frequency- en degree of severity(1) G-IDPBW Janssen Pharmaceutica NV(2)

                                        • frequency rate
                                        • severity

                                        The chart above shows a structurally low frequency (3) and seriousness (4). This is due to the various efforts that are being made in the areas of safety, health and environment. By way of comparison, we cite the frequency of accidents in the sectors that are relevant to us:

                                        • Chemical industry: 10.70
                                        • Pharmaceutical industry: 9,82

                                        (Source: Industrial Accidents Fund, 2011 overview)

                                        • (1)

                                          G-IDPBW: Joint Internal Workplace Health and Safety Department. This joint department has a broader scope than that of the present sustainability report.

                                        • (2)

                                          The scope of the joint internal department of Janssen Pharmaceutica changed in the course of the years cited.

                                        • (3)

                                          The degree of frequency is the number of accidents involving incapacity for work, per million hours worked.

                                        • (4)

                                          The degree of seriousness is the proportion of the number of calendar days actually lost, plus the number of days fixed incapacity for work, per thousand hours worked.

                                        Social
                                        Sustainability

                                        Janssen takes responsibility for its employees, patients and the local and international community.
                                        We therefore work on deploying talent in a sustainable way and take care of the physical and mental health of personnel and their safety and continuing training.

                                        Patient associations receive support from Janssen so they can realize their projects independently. Janssen pays special attention to young persons (training), informs local residents and becomes involved in local projects.

                                        Access to and the affordability of health care are a core international theme at Johnson & Johnson and Janssen, who also support specific philanthropic projects.